The Efficacy and Safety of Once Daily versus Twice Daily Dosing of Caffeine Citrate in Apnea of prematurity: a Randomised Control Trial

Authors

  • Farooq Syed Department of Paediatrics, Mount Zion Medical College, Chayalode Post, Enadimangalam, Kerala 691556, India.
  • Sandesh kini Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka – 576104, India
  • Abdul Majeed Department of Paediatrics, CRAFT Hospital NICU, CRAFT Hospital and Research Centre, Kodungallur, Thrissur, Kerala, India.

DOI:

https://doi.org/10.3126/jnps.v42i1.37173

Keywords:

Randomised control trial, caffeine citrate, apnea of prematurity, efficacy and safety

Abstract

Introduction: Caffeine citrate is widely used for prevention of apnea of prematurity and helps in successful extubation from mechanical ventilation. The optimum caffeine dose in preterm infants with apnea of prematurity has been extensively investigated with varied results. The objective of our study was to compare the efficacy and safety of once versus twice daily maintenance dose of caffeine citrate in premature infants with apnea.

Methods: In this study, preterm neonates with gestational age of 28 to 34 weeks, with evidence of apnea of prematurity were included. Both groups received a 20 mg / kg loading dose of caffeine citrate followed by a maintenance dose of 2.5 mg / kg every 12-hour-interval in group 1 and 5 mg / kg every 24-hour-interval in group 2, either orally or by intravenous infusion. Response to treatment, duration to achieve full feeds, possible adverse reactions were evaluated and compared among the two groups.

Results: Among two groups, group 1 had early reduction in number of apneic episodes on five consecutive days after loading dose, which was statistically significant. Time taken to establish full feeds following treatment initiation was lower in group 1 compared to group 2 (median: Two vs four days) which was statistically significant.

Conclusions: In this study, neonates who received twice daily maintenance dose of caffeine citrate had better outcomes in terms of early reduction in number of apneic episodes and early feed establishment when co

Downloads

Download data is not yet available.
Abstract
177
PDF
174

Downloads

Published

2022-11-27

How to Cite

Syed, F., kini, S., & Majeed, A. . (2022). The Efficacy and Safety of Once Daily versus Twice Daily Dosing of Caffeine Citrate in Apnea of prematurity: a Randomised Control Trial. Journal of Nepal Paediatric Society, 42(1), 124–128. https://doi.org/10.3126/jnps.v42i1.37173

Issue

Vol. 42 No. 1 (2022)

Section

Original Articles

License

Copyright (c) 2022 Farooq Syed, Sandesh kini, Abdul Majeed

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).